HYTANBIO Tirzepatide Research Film
Tirzepatide
Formula, active quantity, film dimensions, flavor and packaging are agreed after project review.
Proposed technical target from supplied table: 2 mg per film. Subject to analytical and feasibility validation.
Key ingredients
- Tirzepatide
Lipid profile and oxidation
An omega-3 film needs a defined EPA/DHA profile, raw-material source and oxidation-control plan. Practical lipid payload and sensory acceptance must be reviewed before selecting a unit format. Oil appearance alone cannot confirm the active profile.
Product direction
Laboratory formulation and analytical evaluation only. Identity, film recovery and stability must be assessed before any project specification is accepted.
Follow the agreed lipid-quality tests in both raw material and finished system where relevant. Source and allergen records belong in the dossier. Cardiovascular terminology is a proposed market position and requires careful substantiation.
Project applications
Laboratory material evaluation, analytical method development and controlled formulation feasibility.
Customization
- Ingredient identity and quantity feasibility
- Film size, thickness and handling criteria
- Flavor and sensory evaluation
- Individual barrier sachet and carton design
- Finished-unit methods and stability plan
- Target-market documentation and label review
Product project specification
| Brand / code | HYTANBIO / R8 |
|---|---|
| Ingredient direction | Tirzepatide |
| Ingredient amount | 2 mg |
| Film thickness reference | Brochure average approximately 0.08 mm; project specification is confirmed separately |
| Packaging | Individual foil sachets; carton and pack count by project |
| MOQ / delivery | Quotation and written schedule after brief review |
Discuss R8 with our project team.
EMAIL: info@hytanbio.com